Diseases & Conditions Market Research Reports & Industry Analysis
Insomnia is a common condition in which one has trouble going to sleep or staying asleep. This condition can range from weak to strong, depending on how often it occurs and for how long. Insomnia can be ongoing or acute. Chronic insomnia means having symptoms at least 3 nights a week for more than a month. Acute insomnia lasts for less time. Some people who have insomnia will have trouble falling asleep. Other people may fall asleep easily but, then wake up.
Diseases & Conditions Industry Research & Market Reports
-
Prostate Cancer Nuclear Medicine Diagnostics Global Market Report 2025
... cancer nuclear medicine diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain ... Read More
-
Allergic Rhinitis - Market Insight, Epidemiology, and Market Forecast - 2034
... of Allergic rhinitis was highest in Japan among the 7MM, accounting for approximately 65 million which is further expected to increase by 2034. The emerging drug REGN5713-5714-5715 is expected to launch in EU4 and the ... Read More
-
Knee Braces
... CAGR of 5.2% over the analysis period 2024-2030. Functional, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$875.4 Million by the end of the analysis period. ... Read More
-
Urothelial Cancer Drugs
... at a CAGR of 20.7% over the analysis period 2024-2030. Immunotherapy, one of the segments analyzed in the report, is expected to record a 20.3% CAGR and reach US$13.3 Billion by the end of the ... Read More
-
mRNA Platform
... CAGR of -2.7% over the analysis period 2024-2030. Covid-19 Vaccine, one of the segments analyzed in the report, is expected to record a -6.3% CAGR and reach US$102.1 Billion by the end of the analysis ... Read More
-
Home Cleaning Services
... at a CAGR of 6.6% over the analysis period 2024-2030. The U.S. Market is Estimated at US$1.8 Billion While China is Forecast to Grow at 9.1% CAGR The Home Cleaning Services market in the U.S. ... Read More
-
Antineoplastic Agents
... CAGR of 7.3% over the analysis period 2024-2030. Chemotherapeutic Agents, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$137.9 Billion by the end of the analysis ... Read More
-
Produce Packaging Trays
... at a CAGR of 4.1% over the analysis period 2024-2030. Growers / Shippers, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$2.0 Billion by the end ... Read More
-
Diabetes Diagnostics
... CAGR of 8.5% over the analysis period 2024-2030. Test Strips, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$14.7 Billion by the end of the analysis ... Read More
-
Migraine Drugs
... CAGR of 16.0% over the analysis period 2024-2030. Acute Treatment, one of the segments analyzed in the report, is expected to record a 16.6% CAGR and reach US$7.2 Billion by the end of the analysis ... Read More
-
Pediatric Epilepsy Therapeutics
... at a CAGR of 3.3% over the analysis period 2024-2030. Third Generation, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$7.0 Billion by the end of ... Read More
-
Therapeutic Respiratory Devices
... at a CAGR of 3.3% over the analysis period 2024-2030. Positive Airway Pressure Devices, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$32.3 Billion by the ... Read More
-
Biomarkers Market Report by Product (Consumables, Services, Software), Type (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers), Disease (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Renal Disorders, and Others), Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, and Others), End User (Pharmaceutical and Biotechnology Companies, Diagnostic and Research Laboratories, Hospitals and Specialty Clinics, and Others), and Region 2025-2033
... rising prevalence of chronic diseases, ongoing developments in biotechnology and genomics, the shift toward personalized medicine, continuous advancements in analytical technologies, and increasing awareness among both healthcare professionals and patients about the benefits of biomarkers ... Read More
-
Prostate Cancer Treatment Market Report by Drug Type (Chemotherapy, Biological Therapy, Hormone Therapy, and Others), Distribution Channel (Hospitals Pharmacies, Drug Stores and Retail Pharmacies, Online Pharmacies), and Region 2025-2033
... 2025-2033. The increasing prevalence of the disease, advancements in personalized medicine, the emergence of new therapies, higher healthcare spending, and growing public awareness about prostate health and available treatment options are strengthening the market growth. ... Read More
-
Intravenous Immunoglobulin (IVIg)
... at a CAGR of 8.5% over the analysis period 2024-2030. IgA, one of the segments analyzed in the report, is expected to record a 10.6% CAGR and reach US$13.7 Billion by the end of the ... Read More
-
Pain Management Devices
... at a CAGR of 7.8% over the analysis period 2024-2030. Neurostimulation Devices, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$3.5 Billion by the end of ... Read More
-
Parkinson’s Disease Drugs
... at a CAGR of 6.5% over the analysis period 2024-2030. Oral, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$4.6 Billion by the end of the ... Read More
-
Blood Glucose Monitoring Systems
... 2030, growing at a CAGR of 10.0% over the analysis period 2024-2030. Self-Monitoring, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$21.4 Billion by the end ... Read More
-
Epilepsy Drugs
... CAGR of 3.8% over the analysis period 2024-2030. First Generation, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$1.6 Billion by the end of the analysis ... Read More
-
Digital Dose Inhalers
... at a CAGR of 12.3% over the analysis period 2024-2030. Metered Dose, one of the segments analyzed in the report, is expected to record a 11.6% CAGR and reach US$4.4 Billion by the end of ... Read More
-
Alginate Dressings
... CAGR of 4.5% over the analysis period 2024-2030. Antimicrobial, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$727.2 Million by the end of the analysis period. ... Read More
-
Medical Refrigerators
... CAGR of 7.0% over the analysis period 2024-2030. Blood Bank Refrigerator & Plasma Freezer, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$2.6 Billion by the ... Read More
-
Metabolic Disorder Therapeutics
... at a CAGR of 6.9% over the analysis period 2024-2030. Diabetes, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$91.9 Billion by the end of the ... Read More
-
Next Generation Cancer Diagnostics
... 2030, growing at a CAGR of 21.8% over the analysis period 2024-2030. qPCR & Multiplexing, one of the segments analyzed in the report, is expected to record a 22.8% CAGR and reach US$28.2 Billion by ... Read More
-
Smart Insulin Pens and Pumps
... Billion by 2030, growing at a CAGR of 8.7% over the analysis period 2024-2030. Pumps, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$7.9 Billion by ... Read More
Research Assistance
